Active Biotech AB (publ) (FRA:BTPC)
Germany
· Delayed Price · Currency is EUR 0.0031
+0.0005 (19.23%)
At close: Dec 4, 2025
Active Biotech AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | - | - | - | - | - | 6.73 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | -20.18% | Upgrade
|
| Gross Profit | - | - | - | - | - | 6.73 | Upgrade
|
| Selling, General & Admin | 12.57 | 13.17 | 13.94 | 15.06 | 15.25 | 13.48 | Upgrade
|
| Research & Development | 26.27 | 26.67 | 32.54 | 42.82 | 34.54 | 25.55 | Upgrade
|
| Operating Expenses | 38.84 | 39.84 | 46.48 | 57.89 | 49.78 | 39.03 | Upgrade
|
| Operating Income | -38.84 | -39.84 | -46.48 | -57.89 | -49.78 | -32.31 | Upgrade
|
| Interest Expense | -0.18 | -0.18 | -0.24 | -0.21 | -0.03 | -0.09 | Upgrade
|
| Interest & Investment Income | 0.55 | 0.65 | 0.29 | 0.05 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | -0.03 | 0.07 | -0.01 | 0.02 | -0.07 | Upgrade
|
| EBT Excluding Unusual Items | -38.5 | -39.4 | -46.37 | -58.05 | -49.79 | -32.46 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.57 | -0.32 | -0.03 | 0.22 | Upgrade
|
| Pretax Income | -38.5 | -39.4 | -45.8 | -58.37 | -49.83 | -32.25 | Upgrade
|
| Net Income | -38.5 | -39.4 | -45.8 | -58.37 | -49.83 | -32.25 | Upgrade
|
| Net Income to Common | -38.5 | -39.4 | -45.8 | -58.37 | -49.83 | -32.25 | Upgrade
|
| Shares Outstanding (Basic) | 1,072 | 420 | 272 | 234 | 214 | 169 | Upgrade
|
| Shares Outstanding (Diluted) | 1,072 | 420 | 272 | 234 | 214 | 169 | Upgrade
|
| Shares Change (YoY) | 211.51% | 54.84% | 16.21% | 9.23% | 26.87% | 16.09% | Upgrade
|
| EPS (Basic) | -0.04 | -0.09 | -0.17 | -0.25 | -0.23 | -0.19 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.09 | -0.17 | -0.25 | -0.23 | -0.19 | Upgrade
|
| Free Cash Flow | -36.92 | -40.42 | -45.74 | -54.85 | -46.17 | -32.22 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.10 | -0.17 | -0.23 | -0.22 | -0.19 | Upgrade
|
| Gross Margin | - | - | - | - | - | 100.00% | Upgrade
|
| Operating Margin | - | - | - | - | - | -480.39% | Upgrade
|
| Profit Margin | - | - | - | - | - | -479.48% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -479.05% | Upgrade
|
| EBITDA | -37.24 | -38.24 | -44.78 | -57.89 | -48.48 | -31.01 | Upgrade
|
| D&A For EBITDA | 1.6 | 1.6 | 1.7 | 0 | 1.3 | 1.3 | Upgrade
|
| EBIT | -38.84 | -39.84 | -46.48 | -57.89 | -49.78 | -32.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.